HRI Malta 2017—Cutting Edge Research in Homeopathy: HRI's Third International Research Conference in Malta by Mosley, Angelina et al.
Article
HRI Malta 2017—Cutting Edge Research in 
Homeopathy: HRI's Third International Research 
Conference in Malta
Mosley, Angelina, Partington, Hazel, Gaertner, Katharina, Fisher, 
Peter, Rutten, A. L. B., Mathie, Robert, Cartwright, Steven, Fixsen, 
Alison, Kokornaczyk, Maria, Sokol, Anezka, Tournier, Alexander and 
Roberts, E.
Available at http://clok.uclan.ac.uk/21560/
Mosley, Angelina, Partington, Hazel ORCID: 0000­0003­3566­7035, Gaertner, Katharina, 
Fisher, Peter, Rutten, A. L. B., Mathie, Robert, Cartwright, Steven, Fixsen, Alison, Kokornaczyk, 
Maria et al (2017) HRI Malta 2017—Cutting Edge Research in Homeopathy: HRI's Third 
International Research Conference in Malta. Homeopathy, 107 (01). 050­054. ISSN 1475­4916  
It is advisable to refer to the publisher’s version if you intend to cite from the work.
http://dx.doi.org/10.1055/s-0037-1609018
For more information about UCLan’s research in this area go to 
http://www.uclan.ac.uk/researchgroups/ and search for <name of research Group>.
For information about Research generally at UCLan please go to 
http://www.uclan.ac.uk/research/ 
All outputs in CLoK are protected by Intellectual Property Rights law, including
Copyright law.  Copyright, IPR and Moral Rights for the works on this site are retained 
by the individual authors and/or other copyright owners. Terms and conditions for use 
of this material are defined in the http://clok.uclan.ac.uk/policies/
CLoK
Central Lancashire online Knowledge
www.clok.uclan.ac.uk
1 
 
CONFERENCE REPORT 
HRI Malta 2017 – Cutting Edge Research in Homeopathy: HRI’s 
third international research conference in Malta   
Angelina J Mosley1, E Rachel Roberts1,*, Hazel Partington2, Katharina Gaertner3, Peter 
Fisher4, Lex ALB Rutten5, Robert T Mathie1, Steven J Cartwright6, Alison Fixsen7, Maria 
Olga Kokornaczyk8, Anezka Marie Sokol9, Alexander L Tournier1 
1Homeopathy Research Institute, London, UK 
2University of Central Lancashire, UK 
3Institute for Complementary Medicine, University of Bern, Switzerland 
4Royal London Hospital for Integrated Medicine, London, UK 
5Independent researcher, Netherlands 
6Cherwell Innovation Centre, Oxford, UK 
7University of Westminster, London, UK 
8Society for Cancer Research, Switzerland 
9Institute of Integrative Medicine, University of Witten-Herdecke, Germany 
 
*Correspondence: E Rachel Roberts, Homeopathy Research Institute, International House, 
124 Cromwell Road, London SW7 4ET, UK 
E-mail: rachelroberts@hri-research.org 
Abstract 
The 3rd international conference on ‘Cutting Edge Research in Homeopathy’ organised by 
the Homeopathy Research Institute (HRI) was held on the inspiring and historic island of 
Malta from 9th–11th of June, 2017. 
102 abstracts underwent peer review by the HRI Scientific Advisory Committee and external 
experts to produce the programme of 36 oral presentations and 37 posters, presented by 
researchers from 19 countries. The two and a half day programme covered a diverse range 
of topics including quantitative and qualitative clinical research, basic research, veterinary 
research and provings. These intensive plenary and parallel sessions were interspersed with 
multiple opportunities for delegates to discuss and exchange ideas, in particular through 
interactive panel discussions and a pre-conference workshop. 
The continuing commitment of the homeopathy research community to generating high 
quality studies in this rapidly evolving field was clear. In this conference report we present 
highlights from this memorable event. 
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Providing a platform for global research 
Following previous conferences in Barcelona (2013) and Rome (2015), the HRI was proud to 
once again host a world-class event in the homeopathy calendar dedicated to ‘Cutting Edge 
Research in Homeopathy’, this time on the island of Malta. As homeopathy continues to face 
significant challenges in many parts of the world, research is playing an ever more vital role 
in the development of homeopathy as an academic field and medical discipline. Within this 
intense international debate HRI Malta 2017 provided a platform for showcasing the latest 
findings from the global homeopathic research community. 
The clinical benefits of an integrated approach 
HRI Malta 2017 was opened by Prof Angela Xuereb, Dean of Health Sciences and Head of 
Applied Biomedical Sciences at the University of Malta. Prof Xuereb reminded the audience 
that the University of Malta is one of the oldest medical schools in the world and provides 
training across different medical disciplines “for the good of the patient”, with collaboration as 
a key guiding principle.  
The benefits of constructive dialogue between different medical disciplines, including 
homeopathy, were further emphasised by our keynote speakers. Prof Michael Frass 
(Germany) and Dr Elio Rossi (Italy), both presented data on the positive role that adjunctive 
homeopathic treatment can play in cancer patients. Drawing on his extensive experience, 
Prof Frass called for an increased use of homeopathy alongside conventional care for 
patients with cancer, listing a wide scope of potential applications. For Prof Frass, the most 
important of these is the enhancement of patients’ quality of life1, which was also echoed by 
Dr Rossi’s presentation based on his work in Lucca, Italy. Dr Emma Macías-Cortés (Mexico) 
presented her keynote address describing a high quality double-blind, double-dummy 
superiority trial, comparing three test groups receiving homeopathy or fluoxetine or placebo; 
this study demonstrated the clinical benefits of individualised homeopathy for peri- and post-
menopausal women with depression2.  
Taken together, these three key presentations highlighted what can be achieved when 
homeopathy is integrated into conventional healthcare. 
Antimicrobial Resistance 
New for HRI Malta 2017 were two interactive panel discussion sessions to further promote 
the exchange of ideas.  
The first session tackled Homeopathy and Antimicrobial Resistance (AMR) – a topic recently 
announced by the World Health Organization (WHO) as one of the main future challenges in 
public health. To set the scene, Dr Peter Fisher’s (UK) presentation emphasised the impact 
of AMR on both human health and the spiralling costs of conventional healthcare; Dr. Alison 
Fixsen  (UK) discussed the evidence of homeopathic interventions in upper respiratory tract 
infections and Petra Klement (Germany) further supported this point, presenting the results 
of a new placebo-controlled trial showing that the homeopathic complex Tonsilotren 
decreased infection rates in patients with recurrent tonsillitis.  
The subsequent panel discussion focused on the problem that despite encouraging results, 
complementary treatment approaches are still not part of the available treatment guidelines 
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for infectious diseases or the global WHO strategy for tackling antimicrobial resistance3. This 
raised the important question of how we can implement and encourage the inclusion of 
homeopathy as a viable contributor to tackling this global problem. 
Systematic reviews of published literature 
As highlighted by the presentations on AMR, analysing the published scientific literature is 
essential for informing future research and clinical guidelines, especially when done using 
the most rigorous methods. Dr Robert Mathie (UK) gave two presentations reporting on his 
programme of systematic reviews. His review of pragmatic trials comparing homeopathy with 
‘other than placebo’ controls identified trials using ‘add-on homeopathy’ as the most 
promising area for future research. His review of double-blind, placebo-controlled 
randomised trials of non-individualised homeopathic treatment found that including model 
validity in assessment of trial “reliability” had an important impact on the results4.  
Dr Katharina Gaertner (Switzerland) presented a systematic review of clinical trials including 
observational studies - an innovative approach as these studies are usually dismissed as 
being lower on the hierarchy of evidence. 
In stark contrast, Rachel Roberts (UK) presented an in-depth analysis and critique of the 
Australian National Health and Medical Research Council’s report on homeopathy. Roberts 
revealed multiple methodological flaws in the ‘Australian Report’ and concluded that these 
errors constitute a case of misfeasance, not unintentional scientific error5. 
Latest clinical research findings 
Three clinical research sessions included recent studies on a wide range of clinical 
conditions. Presentations were given on aggravations after homeopathic treatment in chronic 
conditions (Eizayaga, Argentina), a pilot feasibility study in homeopathy versus usual care 
for attention deficit and hyperactivity disorder (Fibert, UK), the challenges of performing an 
international pilot clinical trial in pre-menstrual syndrome (Klein-Laansma, Netherlands), 
management of recurrent respiratory tract infections with Emtact30 (Shah, India) and the 
potential role of individualised homeopathic treatment as an adjunct in type II diabetic 
patients with poor glycaemic control (To, Hong Kong)6. 
Learning from ‘failed’ studies 
Two further keynote presentations were given by Dr Stephan Baumgartner (Germany) and 
Prof Harald Walach (Germany) who both looked back over two decades of research in their 
respective fields, with the ultimate aim of framing our next steps for future research.  
Dr Baumgartner presented an overview of key experimental models that have demonstrated 
reproducible and reliable differences between ultra-high dilutions and controls. Dr 
Baumgartner also unpicked many problems he faced when performing in vitro and in vivo 
basic experiments on ultra-high dilutions. He stressed that we should not be deterred when 
experiments ‘don’t work’; rather, a deeper understanding of the experimental system often 
reveals the subtle parameters which lead to success or failure of the experiments. For 
example, when we take a broader look at the results of basic research, patterns emerge, 
such as the cyclical response to remedies as a function of varying potency, which Dr 
Baumgartner proposes we call ‘Kolisko-Steiner Patterns’. 
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In the closing keynote address, Prof Walach delivered a thought-provoking presentation on 
the issue of non-reproducibility in provings using a double blind trial design7. Prof Walach 
postulated that the experiences of provers were non-local rendering traditional experimental 
methods problematic. Thus, Prof Walach challenged us to consider that the design of any 
experiment, proving or clinical test automatically creates underlying assumptions about the 
direction of cause and effect of remedies8.  
Addressing the implausibility argument  
Despite the ever-growing body of evidence in fundamental research on homeopathic 
preparations (ultra-high dilutions) the issue of implausibility remains due to the lack of a clear 
mechanism of action.  
Sandra Würtenberger (Germany) addressed this issue, presenting the results of a 
systematic review of physicochemical studies of homeopathic potencies. 72% of the 
included studies detected a difference between control and remedy, or between different 
potencies. The review also identified which physicochemical methods were the most 
promising. Dr Alexander Tournier (Germany) asked the question of whether homeopathy 
really is that implausible, by looking in detail at the physics behind current theories of 
homeopathy’s mechanism of action.  
These overviews were supported by a number of presentations of original laboratory studies 
showing clear differences between ultra-high dilutions and controls using a wide range of 
experimental systems. Presentations given included the effects of Echinacea angustifolia 
and Thuja occidentalis on cervical cancer cells (Aguilar-Velazquez, Mexico), Phosphorus on 
macrophages (Bonamin, Brazil) and the anti-mutagenic effects of a combination remedy in 
vitro (Laurant, France)9; potency interactions with solvatochromic dyes (Cartwright, UK)10; 
and plant models such as the effects of various homeopathic 30x preparations on 
germinating cress seedlings (Sokol, Germany), the reproducibility of Arsenicum album acting 
on duckweed growth rates (Ücker, Germany) and field-like effects of Arsenicum album 45x 
on water and/or wheat seeds (Kokornaczyk, Switzerland). 
Finally, Dr Michel van Wassenhoven (Belgium) presented the DynHom project which seeks 
to systematically address the question of the nature of homeopathic preparations by testing 
two remedies (Cuprum met. and Gelsemium) at different potencies using a host of different 
physicochemical techniques, including trace analysis techniques to investigate the presence 
of nanoparticles.  
Provings 
The clinical application of homeopathy is fundamentally reliant on reliable proving data, and 
as such, this area deserves significant research attention. Prof Ashley Ross (South Africa) 
tackled the fundamental question of whether there is a detectable difference between 
proving symptoms seen in provers taking placebo, compared with those taking verum; Dr 
Robbert van Haselen (France) looked at the validity of proving symptoms when used as 
statistical predictors of treatment success; and Dr Peter Smith (Germany) presented initial 
results of a thematic analysis of 17 provings of sarcodes from the domestic pig performed 
between 1993 and 2017, demonstrating the presence of a consistent core ‘picture’ across 
these remedies. 
5 
 
Qualitative and Veterinary research 
Representing the field of veterinary research, Dr Cidéli Coelho (Brazil) presented the results 
of her work using potencies of Nux Vomica and Papaver somniferum showing significant 
shortening of post-operative recovery times of cats following ovariohysterectomy.  
Qualitative research aims to document experience and find patterns of meaning in it; Dr 
Irene Dorothee Schlingensiepen (Germany) used qualitative research methods to assess the 
relationship between case-taking/prescribing methods and long-term outcomes for her 
patients, confirming the importance of finding the “perfect match” remedy for the best clinical 
outcome. Dr Klaus von Ammon (Switzerland) presented clinical observations made using 
structured qualitative methods exploring remedy responses that seem compatible with 
homeopathic medicines having a ‘field effect’. 
Prognostic factor research  
Prognostic factor research is the systematic study of factors that influence the future 
outcome of a treatment or disease11. In homeopathy research this has been done using 
Bayes’ theorem to assess the likelihood of a relationship between a symptom, remedy and 
clinical outcome. This new approach was highlighted by two presentations in Malta. Firstly, 
Dr Robbert van Haselen presented work on prognostic factor research in provings assessing 
how likely a documented symptom is due to the remedy being proved (see Provings above). 
Secondly, in clinical treatment, Dr Lex Rutten (Netherlands) presented work on prognostic 
factor research on homeopathic symptoms in the treatment of cough12.  
Research priorities for the future 
The second panel discussion – “Research priorities for the future” – opened with a short 
presentation from Hazel Partington and Dr Jean Duckworth (UK) who described preliminary 
results from their Delphi study on this topic. Their study showed that overview research was 
deemed to have had the most impact to date; the most important audiences to reach are 
policy and decision makers, and the consensus was weighted towards clinical research 
being a top priority for future research.  
Following on from this introduction, each panelist (Dr Stephan Baumgartner, Dr Robbert van 
Haselen, Dr Elizabeth Thompson and Dr Alexander Tournier) gave a brief summary of what 
they felt were the priorities for future research before inviting delegates to contribute. The 
ensuing discussion covered the need for mixed portfolios of evidence, the advantages of 
pragmatic trials and cohort studies, focusing on ‘effectiveness gap’ conditions, considering 
how clinicians use evidence and a reminder that priorities may be different in countries 
where attitudes to homeopathy are different.  
Investing in the future of homeopathy research 
Certain aspects of the Malta Conference were designed specifically to help the Institute fulfil 
its aim of fostering new high quality research in homeopathy. Firstly, the pre-conference 
workshop entitled “Making studies count – avoiding common pitfalls in homeopathy 
research” highlighted ways in which the research community can collaborate to ensure that 
new studies are in the best strategic direction, take the latest knowledge into consideration 
and do not repeat old mistakes. Following presentations from Dr Robert Mathie and Dr 
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Stephan Baumgartner, workshop attendees were encouraged to examine and discuss 
practical aspects which should be considered when building trials and experiments. 
In addition, HRI was delighted to award HRI Educational Grants to 15 UK-resident 
homeopaths and researchers, supporting conference attendance. This direct financial 
support gave the next generation of homeopathy researchers the opportunity to sample the 
best research currently available, as well as supporting established researchers in 
disseminating their findings. 
Conclusion 
Looking back, HRI Barcelona 2013 was a unique challenge insofar as people told us that it 
would not be possible to hold a conference dedicated solely to homeopathy research; thanks 
to the support of our colleagues we were delighted that our inaugural conference was in fact 
a success. This was followed by Rome 2015, which came at a time of controversy with 
publication of the damming Australian report13, the effects of which are still being felt 
worldwide, two years later. Against this backdrop it was rewarding to hear so many people 
saying that HRI Malta 2017 was our best conference yet. But seeing the conference close 
with a spontaneous standing ovation was totally unexpected and incredibly moving.  
We are proud of the work that the HRI conference team put into Malta and inspired by our 
colleagues around the world who continue their research undeterred by external pressures. 
Despite obstacles that at times can seem overwhelming, HRI conferences demonstrate the 
clear commitment of the homeopathy research community to move forward confidently, 
striving to improve our skills and generating data of ever-higher quality.  
With the resounding success of HRI Malta 2017 still fresh in our minds, plans are already 
underway to bring you another instalment of Cutting Edge Research in Homeopathy. We 
look forward to inviting friends, old and new, to join us for HRI London 2019. 
Full details of HRI Malta 2017 can be found on the microsite, www.hrimalta2017.org. 
Information about HRI London 2019 is available on the organisation’s website, www.hri-
research.org. 
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